Nonsegmental Vitiligo

For adults (≥ 18 yo) with chronic spontaneous urticaria (subcutaneous study drug)

CLINICAL TRIAL

RECRUITING

Phase 3 | Oral tablet | 52 weeks

CLINICAL TRIAL

CLOSED

Phase 3 | Oral tablet | 48-112 weeks

Learn More About This Trial

Full Name

Email

Phone Number

Nonsegmental Vitiligo Trial ID

How can we help you?

Have you read ALL of the Eligibility Criteria for your interested trial? (Found by clicking the Trial ID in the chosen Clinical Trial)

Yes

No

Thank you for contacting us.
We will get back to you as soon as possible.

Oops, there was an error sending your message.
Please try again later.